Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. | ![]() Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | ![]() Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | ||
Founding Date | Founding Date 2006 | Founding Date 2014 | Founding Date 2019 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Rye, US HQ Rye Brook, US | Locations San Diego, US HQ | Locations Boston, US HQ | Locations Utrecht, NL HQ Utrecht, NL |
Employees | Employees 23 | Employees 3939% increase | Employees 41 | Employees 28 |
Funding | ||||
Latest funding round | Latest funding round $ 5.4m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 65m (over 4 years ago) | Latest funding round $ 24m (about 6 years ago) |
Total funding raised | Total funding raised $ 55.7m | Total funding raised $ 79m | Total funding raised $ 65m | Total funding raised $ 210.3m |

Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View companyAM-Pharma is a biopharmaceutical company that develops medicines for patients.
View company